CORDANI, NICOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.520
EU - Europa 1.708
AS - Asia 789
SA - Sud America 39
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 5.065
Nazione #
US - Stati Uniti d'America 2.475
IT - Italia 707
SG - Singapore 361
IE - Irlanda 195
DE - Germania 185
CN - Cina 175
SE - Svezia 164
RU - Federazione Russa 115
HK - Hong Kong 103
UA - Ucraina 88
GB - Regno Unito 60
ID - Indonesia 54
FR - Francia 52
CA - Canada 43
IN - India 42
FI - Finlandia 39
BR - Brasile 35
NL - Olanda 30
TR - Turchia 16
DK - Danimarca 14
VN - Vietnam 14
AT - Austria 13
BE - Belgio 12
JP - Giappone 11
PL - Polonia 6
EU - Europa 4
IR - Iran 4
BG - Bulgaria 3
MT - Malta 3
RO - Romania 3
AL - Albania 2
AR - Argentina 2
BY - Bielorussia 2
CH - Svizzera 2
ES - Italia 2
GR - Grecia 2
KR - Corea 2
LT - Lituania 2
LV - Lettonia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
PR - Porto Rico 1
SN - Senegal 1
Totale 5.065
Città #
Ann Arbor 574
Milan 295
Singapore 219
Woodbridge 219
Chandler 203
Dublin 189
Fairfield 168
Houston 141
Frankfurt am Main 123
Wilmington 108
Hong Kong 102
Ashburn 97
Jacksonville 92
New York 85
Seattle 78
Dearborn 69
Cambridge 62
Santa Clara 58
Jakarta 52
Princeton 38
Nanjing 37
Shanghai 34
Lissone 27
Rome 26
Helsinki 17
Lawrence 17
Beijing 16
Boardman 16
Los Angeles 16
Lachine 15
Monza 14
Brussels 12
Carate Brianza 12
Desio 12
Nanchang 12
Nuremberg 11
Pune 11
San Diego 11
Altamura 10
Cinisello Balsamo 10
Ottawa 10
Chicago 9
Paris 9
Seregno 9
Council Bluffs 8
Munich 8
Shenyang 8
Tianjin 8
Andover 7
Hebei 7
London 7
Romola 7
Toronto 7
Genoa 6
Lappeenranta 6
Lecco 6
Portici 6
Vienna 6
Amsterdam 5
Cassano Magnago 5
Dallas 5
Dong Ket 5
Edmonton 5
Falls Church 5
Florence 5
Fremont 5
Hangzhou 5
Lodz 5
Mumbai 5
Norwalk 5
Olgiate Comasco 5
Peschiera Borromeo 5
Auburn Hills 4
Bergamo 4
Gallarate 4
Huizen 4
Jiaxing 4
Limbiate 4
Meaux 4
Montréal 4
Palermo 4
Tokyo 4
Trieste 4
Turin 4
Zhengzhou 4
Ardea 3
Changchun 3
Changsha 3
Corsico 3
Delhi 3
Guangzhou 3
Hyderabad 3
Jinan 3
Lanzhou 3
Marano di Napoli 3
Marino 3
Marseille 3
Melita 3
Melzo 3
Modena 3
Totale 3.609
Nome #
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 366
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 294
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 282
Chronic myeloid leukemia: Second-line drugs of choice 274
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 270
Expression of heat shock protein 27 in human renal cell carcinoma 220
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 219
Isolation of FAP Cells from Mouse Dystrophic Skeletal Muscle Using Fluorescence Activated Cell Sorting 197
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes 187
Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma 182
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues 170
Nitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro-Adipogenic Precursor Differentiation 159
Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts 158
Comparative proteomics of membrane microdomains from renal cell carcinoma and adiacent normal kidney 156
Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases 155
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 150
The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFN alpha on pleomorphic sarcoma cells 125
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 122
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 115
Derangement of endothelial protein C receptor and thrombomodulin expression in the intestinal mucosa of patients with inflammatory bowel diseases 115
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 110
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease 110
EGFR overexpression in malignant pleural mesothelioma: An immunohistochemical and molecular study with clinico-pathological correlations 110
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 107
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 97
Investigation of the origin of malignant fibrous histiocytoma and identification of specific predictive markers for this tumour 97
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 93
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 74
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows 70
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 64
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 63
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 61
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 58
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study 56
Metronomic chemotherapy 51
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons 47
Edaravone: A Novel Possible Drug for Cancer Treatment? 38
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 25
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer 24
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 4
Totale 5.275
Categoria #
all - tutte 20.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.077


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202095 0 0 0 0 0 0 0 0 0 41 43 11
2020/2021593 26 26 63 68 62 61 58 41 44 55 36 53
2021/2022293 30 42 48 32 8 21 13 15 11 19 21 33
2022/2023763 48 200 39 91 46 72 43 40 36 64 48 36
2023/2024906 50 50 32 51 115 187 146 40 53 39 41 102
2024/20251.269 121 181 147 120 191 88 140 56 224 1 0 0
Totale 5.275